Antonella Torosantucci Selected Research

Antonella Torosantucci Research Topics

6	Infections 12/2020 - 09/2005
5	Mycoses (Diseases, Fungus) 12/2020 - 12/2006
5	Candidiasis (Moniliasis) 02/2010 - 01/2002
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Systemic candidiasis 01/2009
1	Hypersensitivity (Allergy) 09/2005
1	Invasive Candidiasis 10/2002
1	Oral Candidiasis (Thrush) 01/2002

5	AntibodiesIBA 01/2017 - 10/2002
4	VaccinesIBA 03/2010 - 10/2002
4	beta-GlucansIBA 03/2010 - 12/2006
2	GlucansIBA 09/2011 - 02/2007
2	laminaranIBA 03/2010 - 12/2006
2	Conjugate VaccinesIBA 03/2010 - 02/2010
2	Immunoglobulin G (IgG)IBA 02/2010 - 01/2009
1	CRM197 (non-toxic variant of diphtheria toxin)IBA 03/2010
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 03/2010
1	EpitopesIBA 03/2010
1	OligosaccharidesIBA 03/2010
1	MF59 oil emulsionIBA 02/2010
1	Estrogens (Estrogen)FDA Link 03/2008
1	Biological ProductsIBA 03/2008
1	PlasticsIBA 03/2008
1	Polysaccharides (Glycans)IBA 03/2008
1	Pharmaceutical PreparationsIBA 03/2008
1	Proteins (Proteins, Gene)FDA Link 12/2006
1	AntigensIBA 09/2005
1	CytokinesIBA 09/2005
1	lipoarabinomannan (LAM)IBA 09/2005
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2002
1	HIV Protease InhibitorsIBA 01/2002
1	Reverse Transcriptase InhibitorsIBA 01/2002
1	Aspartic Acid ProteasesIBA 01/2002

2	Therapeutics 12/2020 - 01/2002
2	Immunotherapy 12/2020 - 09/2011
1	Highly Active Antiretroviral Therapy (HAART) 01/2002